BR9701313A - Composições que contêm uma associação de aspririna e um oligossacarídeo anti-xa e uso de um olissacarídeo anti-xa opicionalmente em combinação com aspirina - Google Patents

Composições que contêm uma associação de aspririna e um oligossacarídeo anti-xa e uso de um olissacarídeo anti-xa opicionalmente em combinação com aspirina

Info

Publication number
BR9701313A
BR9701313A BR9701313A BR9701313A BR9701313A BR 9701313 A BR9701313 A BR 9701313A BR 9701313 A BR9701313 A BR 9701313A BR 9701313 A BR9701313 A BR 9701313A BR 9701313 A BR9701313 A BR 9701313A
Authority
BR
Brazil
Prior art keywords
aspririn
olysaccharide
aspirin
oligosaccharide
association
Prior art date
Application number
BR9701313A
Other languages
English (en)
Portuguese (pt)
Inventor
Roger Cariou
Jacobus Christianus J Stiekema
Original Assignee
Sanofi Sa
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA002199642A priority Critical patent/CA2199642C/fr
Priority to EA199700025A priority patent/EA000048B1/ru
Priority to AU16319/97A priority patent/AU698456B2/en
Application filed by Sanofi Sa, Akzo Nobel Nv filed Critical Sanofi Sa
Priority to BR9701313A priority patent/BR9701313A/pt
Publication of BR9701313A publication Critical patent/BR9701313A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9701313A 1997-03-10 1997-03-17 Composições que contêm uma associação de aspririna e um oligossacarídeo anti-xa e uso de um olissacarídeo anti-xa opicionalmente em combinação com aspirina BR9701313A (pt)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002199642A CA2199642C (fr) 1997-03-10 1997-03-10 Compositions associant l'aspirine et un oligosaccharide anti-xa et utilisation d'un oligosaccharide anti-xa facultativement associe a l'aspirine
EA199700025A EA000048B1 (ru) 1997-03-10 1997-03-13 Применение олигосахарида и аспирина для лечения тромбоэболических заболеваний, фармацевтическая композиция, способ лечения
AU16319/97A AU698456B2 (en) 1997-03-10 1997-03-14 Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin
BR9701313A BR9701313A (pt) 1997-03-10 1997-03-17 Composições que contêm uma associação de aspririna e um oligossacarídeo anti-xa e uso de um olissacarídeo anti-xa opicionalmente em combinação com aspirina

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002199642A CA2199642C (fr) 1997-03-10 1997-03-10 Compositions associant l'aspirine et un oligosaccharide anti-xa et utilisation d'un oligosaccharide anti-xa facultativement associe a l'aspirine
AU16319/97A AU698456B2 (en) 1997-03-10 1997-03-14 Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin
BR9701313A BR9701313A (pt) 1997-03-10 1997-03-17 Composições que contêm uma associação de aspririna e um oligossacarídeo anti-xa e uso de um olissacarídeo anti-xa opicionalmente em combinação com aspirina

Publications (1)

Publication Number Publication Date
BR9701313A true BR9701313A (pt) 1998-11-17

Family

ID=27152254

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9701313A BR9701313A (pt) 1997-03-10 1997-03-17 Composições que contêm uma associação de aspririna e um oligossacarídeo anti-xa e uso de um olissacarídeo anti-xa opicionalmente em combinação com aspirina

Country Status (4)

Country Link
AU (1) AU698456B2 (fr)
BR (1) BR9701313A (fr)
CA (1) CA2199642C (fr)
EA (1) EA000048B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794412B1 (en) * 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
UA80399C2 (en) * 2001-11-13 2007-09-25 Glaxo Group Ltd Use of specific dose of fondaparinux sodium for the treatment of acs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
FR2564468B1 (fr) * 1984-05-16 1994-12-23 Choay Sa Nouveaux oligosaccharides, leur preparation par voie de synthese et leurs applications biologiques

Also Published As

Publication number Publication date
CA2199642C (fr) 2001-05-08
EA000048B1 (ru) 1998-04-30
EA199700025A1 (ru) 1997-12-30
AU1631997A (en) 1998-09-17
AU698456B2 (en) 1998-10-29
CA2199642A1 (fr) 1998-09-10

Similar Documents

Publication Publication Date Title
FI954963L (fi) Poly-1-n-alkeeniamiineja ja näitä sisältäviä poltto- ja voiteluainekoostumuksia
BR9509103A (pt) Composição desinfetante que é compatível com gêneros alimentícios e bebidas
FI965293L (fi) Metkonatsolia ja muuta triatsolia sisältävät synergistiset koostumukset
PT978276E (pt) Comprimidos com revestimento de polimero que compreendem amoxicilina e clavulanato
PT1270565E (pt) Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia
FI964334L (fi) Polymeroitava koostumus ja sen käyttö
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
IL123887A0 (en) Dithiolan derivatives their use and pharmaceutical compositions containing the same
BR9601693A (pt) Composição e seus usos
PT946185E (pt) Composicao farmaceutica compreendendo um composto que possui actividade anti-xa e um composto antagonista da agregacao plaquetaria
FI954520L (fi) Alkyyliglykosidi ja sen käyttö
FI955851L (fi) Synergistisesti stabiloituja nestemäisiä entsymaattisia koostumuksia
ZA994521B (en) Composition containing an opacifier or pearlescent agent and at least one fatty alcohol.
BR9710666A (pt) Lan-adeira para uso na inser-Æo de uma linha de tra-Æo em um encanamento
BR9707808A (pt) Composto composição farmacêutica e uso do composto
BR8901727A (pt) Composicao organopolissiloxana estavel em ausencia de unidade e endurecivel em um elastomero
BR9603758A (pt) Composição aglutinante isenta de solventes e seu uso em composições de revestimento de um e dois componentes
FI960487A7 (fi) Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia
FI963394L (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
PT863878E (pt) Nitronas ciclicas e composicoes farmaceuticas que as contem
PT839512E (pt) Composicao de gel cosmetico plastificado com elevado teor em agua e lapis que o contem
AU1631997A (en) Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin
DE69920272D1 (de) Durchsichtige oder lichtdurchlässige flüssige enzym- und antioxidantenthaltende zusammensetzungen in klaren flaschen
EP0682072A3 (fr) Composition de résine et structure stratifiée contenant cette composition.
BR9612370A (pt) Sílica trata com uma geléia oleosapolimérica e uso da sílica

Legal Events

Date Code Title Description
TE Change of address
PC Transfer

Free format text: AKZO NOBEL N.V. (NL), SANOFI SYNTHELABO (FR)

B25A Requested transfer of rights approved

Owner name: SANOFI-SYNTHELABO (FR)

Free format text: TRANSFERIDO DE: AKZO NOBEL N.V.

B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 31/715, A61K 31/19

Ipc: C07H 17/04 (2009.01), C07C 65/00 (2009.01), A61K 3

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O E 13 DA LEI 9279/96.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.